CDAKQ — Codiak BioSciences,. Share News
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.06m
- -$26.01m
- $22.94m
Codiak BioSciences Inc: Falls in Nasdaq debut
Brief: Codiak Biosciences Shares Open 6% Below IPO Price In NASDAQ Debut
NASDAQ TRADE HALT REASON NOT AVAILABLE AT 04:00 AM
Brief: Codiak BioSciences Announces Pricing Of Initial Public Offering
Brief: Codiak Biosciences Inc Sees IPO Of Up To 5.5 Million Shares Of Common Stock To Be Priced Between $14.00 And $16.00 Per Share
Brief: Codiak Initiates Patient Dosing In Phase 1/2 Clinical Trial Of Exosting For The Treatment Of Solid Tumors
Brief: Codiak Initiates Subject Dosing In A Phase 1 Clinical Trial Of exoIL-12™ For The Treatment Of Cancer
Brief: Codiak Biosciences Files To Withdraw IPO Plans